
南微医学
内窥镜下微创诊疗器械研发商
南微医学是一家成立于2000年5月,总部位于中国南京市的内窥镜下微创诊疗器械研发商,创始人为隆晓辉;2019年7月22日,南微医学在上交所上市;主要股东为南京新微创企业管理咨询有限公司、深圳市中科招商创业投资有限公司、Huakang Limited;在中国和全球范围内,和南微医学在业务上有不同程度竞争关系的公司包括天松医疗、爱科凯能、Gordian Surgical、COOP GROUP等。
We-Linking Raised Over CNY 10 Mn in Angel Round
Intraoperative Neurophysiological Monitoring Equipment Developer NeuroFlag Closed An Angel Round
IntoCare Zhang Hui: Ingenuity Forges Quality, Continuous Improvement Safeguards Lives
In 2024, nearly all medical enterprises are exploring overseas markets. This trend is driven by an anti-corruption wave within the medical industry, the demand for financing and initial public offerings, as well as challenges such as excess production capacity. Presently, venturing abroad has become an essential developmental path for medical device enterprises. Successfully entering foreign markets is not only a crucial means for the medical industry to achieve a second grow
May 09, 2024 12:18 PM
Innovative Drug Developer Rezu Bio Raised CNY 10 Mn in Series Pre-A
ZD Medtech Raised Over CNY 100 Mn in Series B
Smart Powered Bionic Prosthetic Star BionicM Nets Over CNY 10 Mn
Medical Technology Company MacroLux Nets Nearly CNY 100 Mn in Series A
ForLong Biotech Nets Over CNY 100 Mn in Series A
CytoCan Corp. Nets CNY 10 Mn in Seed Round
Fine Vision Completes Angel Financing Round Worth Nearly CNY 50 Mn
Hillhouse increased its research efforts, and huitai medical and other companies were favored
China's First Modified New Drug of Docetaxel Successfully Went to the US
Feb 19, 2025 10:41 AM
Medical device stocks rose sharply in the afternoon
Pharmaceutical and medical stocks fell sharply in early trading, and Hengrui pharmaceutical fell more than 9%
Medical stocks of science and technology innovation board fell sharply